Clinical Trial

Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial

Study acronym: CXL-RCT
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine whether corneal collagen crosslinking is effective in the treatment of progressive keratoconus.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2012-05-21; most recent amendment 2026-05-06.
Status change: Recruiting → Active, Not Recruiting 2021-04-13
Trial Details
NCT Number NCT01604135
Lead Sponsor Sahlgrenska University Hospital
Collaborators: Göteborg University
Conditions Keratoconus
Enrollment 36 participants
Start Date 2012-05
Primary Completion 2027-04 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-11